NP2 is a leader in nonprofit pharma. We believe that everyone—regardless of income or life circumstances— should have access to the life-saving medicines they need. NP2’s innovative model will reduce rapidly escalating generic drug prices for some of the most widely used oncology drugs and those used to treat infectious diseases and more.
average cost of one year of cancer treatment in the U.S. in 2019
of cancer patients in the U.S. experience financial hardship in affording their treatment
of U.S. cancer patients do not complete their treatment due to the high cost of care
Americans have experienced medication insecurity in the last 12 months
NP2 needs your help to ensure that all Americans have access to the life-saving medicines they need. Be a changemaker and help us create a new paradigm—one that puts public health ahead of profits. Your tax-deductible donation will help us lower the cost of generic drugs for the under-served and for all Americans, today, tomorrow, and for years to come.
“NP2 is tackling one of the most significant health crises facing millions of Americans—the sky-rocketing cost of generic life-saving drugs. I am proud to support NP2 in creating a new model that will put people ahead of profits. The time is now to change the old paradigm and NP2 is just the organization to do it. “
Michael Parr, MD, Addiction Medicine Specialist
“NP2 is an incredibly important venture…It is good for patients, good for hospitals and good for research.”
Steve Libutti, MD, Director, Rutgers Cancer Institute
“NP2 exemplifies what’s right about the biopharma industry. Using their powerful, combined expertise, these pharma veterans are creating fairly priced, life-saving or sustaining generic medications for patients who really need them. I am highly enthusiastic to support their remarkably uncommon efforts.”
David Hardy, MD, Adjunct Clinical Professor of Medicine, University of Southern California
“As a patient, I know of the devastating financial consequences of having a complex illness that required extensive and expensive treatment over a long period of time. Despite having health insurance I still had to borrow money from family and go into debt to cover the cost of my care. No one in America should be faced with this kind of stress when their energy should be focused on getting well. I am grateful for NP2 and their bold new model to bring down the cost of pharmaceutical care.”
C.J. Simon, NP2 supporter
Kahaari Kenyatta, Drug Pricing Policy Analyst